Alphataxin was shown here to effectively elevate CD4+ T cell numbers and CD4/CD8 T cell ratios both in circulation and within tumors in non-tumor bearing mice and in two orthotopic renal adenocarcinoma mouse studies. Here, CD8A is linked to papillary renal cell carcinoma.